The 'nivolution' in renal cell carcinoma: behind the scenes of clinical trials.

作者信息

Buti Sebastiano, Bersanelli Melissa

机构信息

Medical Oncology, University Hospital of Parma, Italy.

出版信息

Future Oncol. 2016 Sep;12(18):2061-3. doi: 10.2217/fon-2016-0040. Epub 2016 May 11.

DOI:10.2217/fon-2016-0040

PMID:27168416

Abstract

摘要

相似文献

[1]

The 'nivolution' in renal cell carcinoma: behind the scenes of clinical trials.

Future Oncol. 2016-9

[2]

Immune Checkpoint Therapy in Renal Cell Carcinoma.

Cancer J. 2016

[3]

Clinical use of checkpoint inhibition in kidney cancer.

Clin Adv Hematol Oncol. 2016-6

[4]

Nivolumab: targeting PD-1 to bolster antitumor immunity.

Future Oncol. 2015

[5]

Programmed death-1 inhibition in renal cell carcinoma: clinical insights and future directions.

Clin Adv Hematol Oncol. 2014-2

[6]

[Immunotherapy of renal cell cancer].

Magy Onkol. 2017-6-6

[7]

Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma.

Drugs. 2018-9

[8]

Nivolumab plus ipilimumab in advanced renal-cell carcinoma.

Lancet Oncol. 2018-5

[9]

Atypical responses in patients with advanced melanoma, lung cancer, renal-cell carcinoma and other solid tumors treated with anti-PD-1 drugs: A systematic review.

Cancer Treat Rev. 2017-7-19

[10]

The science of checkpoint inhibition in kidney cancer.

Clin Adv Hematol Oncol. 2016-4

引用本文的文献

[1]

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential.

Ther Adv Med Oncol. 2017-10

[2]

From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis.

World J Clin Oncol. 2017-2-10

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

The 'nivolution' in renal cell carcinoma: behind the scenes of clinical trials.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献